Clinical Laserthermia Systems AB Class B (LS60) Stock Statistics & Valuation Metrics

Clinical Laserthermia Systems AB Class B has a market cap or net worth of €20.38M. The enterprise value is €214.18M.

Clinical Laserthermia Systems AB Class B has 31,163,593 shares outstanding. The number of shares has decreased by -2.65% in one year.

Clinical Laserthermia Systems AB Class B’s return on equity (ROE) is -0.69 and return on invested capital (ROIC) is -82.32%.

The current PE Ratio of Clinical Laserthermia Systems AB Class B is ―. Clinical Laserthermia Systems AB Class B’s PEG ratio is 0.01.

In the last 12 months, Clinical Laserthermia Systems AB Class B had revenue of 18.78M and earned -47.62M in profits. Earnings per share was -4.33.

In the last 12 months, operating cash flow was -33.42M and capital expenditures -6.19M, giving a free cash flow of -39.61M billion.

Clinical Laserthermia Systems AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―

Clinical Laserthermia Systems AB Class B upcoming earnings date is Feb 20, 2026, TBA (Confirmed).

Clinical Laserthermia Systems AB Class B as a current ratio of 2.99, with Debt / Equity ratio of 0.38%

In the past 12 months, Clinical Laserthermia Systems AB Class B has paid 0.00 in taxes.

Clinical Laserthermia Systems AB Class B EV to EBITDA ratio is -0.40, with an EV/FCF ratio of -0.31.

Clinical Laserthermia Systems AB Class B has €13.20M in cash and marketable securities with €224.00K in debt, giving a net cash position of €12.97M billion.

Gross margin is 67.13%, with operating margin of -288.85%, and net profit margin of -253.54%.

The average price target for Clinical Laserthermia Systems AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―